RTW Biotech Opportunities (LON:RTW – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as GBX 2.49 and last traded at GBX 2.45, with a volume of 98661 shares traded. The stock had previously closed at GBX 2.48.
RTW Biotech Opportunities Stock Up 1.6%
The stock has a market capitalization of £8.04 million, a P/E ratio of 0.04 and a beta of 0.76. The stock has a 50 day moving average price of GBX 2.33 and a 200-day moving average price of GBX 2.18. The company has a debt-to-equity ratio of 20.05, a current ratio of 0.15 and a quick ratio of 0.81.
RTW Biotech Opportunities Company Profile
RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.
Featured Articles
- Five stocks we like better than RTW Biotech Opportunities
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for RTW Biotech Opportunities Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTW Biotech Opportunities and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
